The next wave of technological advancement in biotechnology and the pharma industry is about bringing convenience and ease to the administration of drugs. The growth in the injectable market and increasing awareness of self-administration are driving pharma companies to come up with new and innovative products with increased drug delivery convenience and safety. In the customized medical injectable market, one company that has started gaining traction is Unilife (UNIS).
Understanding the business:
The company is in the business of design, development, manufacturing, and supply of injectable products. Its products are designed with focus on safety that removes risk of needle-stick injury and unsafe injection practices.
Unilife has four main sources of revenue:
1. Customization program: In...
Only subscribers can access this article, which is part of the PRO research library covering 3,589 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: